Capital Research Global Investors 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 2:14 pm Sale | 2024-12-31 | 13G | Denali Therapeutics Inc. DNLI | Capital Research Global Investors | 5,477,211 3.800% | -2,431,903 (-30.75%) | Filing |
| 2024-11-12 12:52 pm Purchase | 2024-11-07 | 13G | Denali Therapeutics Inc. DNLI | Capital Research Global Investors | 7,909,114 5.500% | 7,909,114 (New Position) | Filing |